Cory Scott Newland

Title: Innovations by Cory Scott Newland

Introduction

Cory Scott Newland is an accomplished inventor based in Tucson, AZ. He has made significant contributions to the field of medical diagnostics, particularly in the detection of viral pathogens. With a total of 3 patents to his name, Newland's work is at the forefront of innovative solutions for public health challenges.

Latest Patents

Newland's latest patents include groundbreaking methods for detecting low levels of the COVID-19 virus. One of his notable inventions provides a method for detecting the presence of the COVID-19 virus in human or environmental samples. This method involves processing samples to obtain total nucleic acids, which are then used in a reverse transcription-amplification reaction to produce cDNA. This cDNA is utilized in a PCR amplification reaction to generate fluorescent COVID-19 virus-specific amplicons, which can be detected by microarray hybridization near the lowest limit of detection. Additionally, this method allows for the detection of other respiratory disease-causing pathogens, including viruses, bacteria, and fungi, in a single assay.

Another significant patent is a combinatorial microarray assay for clade variant detection. This method enables the detection of clade variants in the COVID-19 virus from human or environmental samples. The process involves obtaining total RNA from samples, which is then used as a template in a combined reverse transcription and amplification reaction to produce fluorescent COVID-19 virus amplicons. These amplicons are hybridized on a microarray with nucleic acid probes that can distinguish among various clade variants. The microarray is imaged to detect the clade variant, and a unique intensity distribution profile is generated for each clade variant.

Career Highlights

Cory Scott Newland is currently associated with Pathogendx, Inc., where he continues to innovate in the field of pathogen detection. His work is crucial in addressing the challenges posed by infectious diseases, particularly in the context of the ongoing global health crisis.

Collaborations

Newland collaborates with notable colleagues, including Frederick Henry Eggers and Benjamin Alan Katchman. Their combined expertise enhances the research and development efforts at Pathogendx, Inc.

Conclusion

Cory Scott Newland's contributions to medical diagnostics through his innovative patents are vital in the fight against infectious diseases. His work exemplifies the importance of innovation in public